{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:36:31Z","timestamp":1787164591513,"version":"build-2736575974"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1093\/jac\/dky180","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T15:09:17Z","timestamp":1524150557000},"page":"2137-2140","source":"Crossref","is-referenced-by-count":4,"title":["A multivariate genetic analysis confirms rs5010528 in the human leucocyte antigen-C locus as a significant contributor to Stevens-Johnson syndrome\/toxic epidermal necrolysis susceptibility in a Mozambique HIV population treated with nevirapine"],"prefix":"10.1093","volume":"73","author":[{"given":"Cinzia","family":"Ciccacci","sequence":"first","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Politi","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Mancinelli","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"},{"name":"DREAM Programme, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Ciccacci","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"},{"name":"DREAM Programme, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lucaroni","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Novelli","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Marazzi","sequence":"additional","affiliation":[{"name":"DREAM Programme, Rome, Italy"},{"name":"Department of Human Studies, LUMSA University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Palombi","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"},{"name":"DREAM Programme, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Borgiani","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"key\n\t\t\t\t20180720035930_dky180-B1","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(04)15997-7","article-title":"Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study","volume":"363","author":"van Leth","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180720035930_dky180-B2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1468-1293.2006.00386.x","article-title":"Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women","volume":"7","author":"Marazzi","year":"2006","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180720035930_dky180-B3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1742-7843.2011.00780.x","article-title":"Pharmacogenetics of toxicity, plasma trough concentration and treatment outcome with nevirapine-containing regimen in anti-retroviral-na\u00efve HIV-infected adults: an exploratory study of the TRIANON ANRS 081 trial","volume":"109","author":"Gozalo","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"key\n\t\t\t\t20180720035930_dky180-B4","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00126334-200309011-00005","article-title":"A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients","volume":"34","author":"Stern","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180720035930_dky180-B5","doi-asserted-by":"crossref","first-page":"e12617.","DOI":"10.1371\/journal.pone.0012617","article-title":"Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication","volume":"5","author":"Aaron","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180720035930_dky180-B6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1471-2334-10-188","article-title":"Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, C\u00f4te d'Ivoire","volume":"10","author":"Coffie","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180720035930_dky180-B7","first-page":"163","article-title":"Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria","volume":"6","author":"Shakil","year":"2000","journal-title":"Liver Transpl"},{"key":"key\n\t\t\t\t20180720035930_dky180-B8","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/QAD.0b013e32835f1db0","article-title":"Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis","volume":"27","author":"Shubber","year":"2013","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180720035930_dky180-B9","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.2217\/pgs.15.128","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reaction","volume":"16","author":"Rufini","year":"2015","journal-title":"Pharmacogenomics"},{"key":"key\n\t\t\t\t20180720035930_dky180-B10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1089\/aid.2011.0107","article-title":"HLA-dependent hypersensitivity reaction to nevirapine in Chinese Han HIV-infected patients","volume":"28","author":"Gao","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180720035930_dky180-B11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-6405-6-22","article-title":"HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients","volume":"6","author":"Likanonsakul","year":"2009","journal-title":"AIDS Res Ther"},{"key":"key\n\t\t\t\t20180720035930_dky180-B12","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00228-013-1549-x","article-title":"Association between CYP2B6 polymorphisms and Nevirapine-induced SJS\/TEN: a pharmacogenetics study","volume":"69","author":"Ciccacci","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180720035930_dky180-B13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00228-013-1622-5","article-title":"HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons syndrome\/toxic epidermal necrolysis susceptibility in a population from Mozambique","volume":"70","author":"Borgiani","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180720035930_dky180-B14","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.3390\/ijms16035830","article-title":"A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS\/TEN susceptibility","volume":"16","author":"Ciccacci","year":"2015","journal-title":"Int J Mol Sci"},{"key":"key\n\t\t\t\t20180720035930_dky180-B15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00228-017-2295-2","article-title":"Impact of glutathione transferases genes polymorphisms in nevirapine adverse reactions: a possible role for GSTM1 in SJS\/TEN susceptibility","volume":"73","author":"Ciccacci","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20180720035930_dky180-B16","first-page":"1152","article-title":"Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population","volume":"72","author":"Carr","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180720035930_dky180-B17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/pgs.09.142","article-title":"Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique","volume":"11","author":"Ciccacci","year":"2010","journal-title":"Pharmacogenomics"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/8\/2137\/25178828\/dky180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T02:15:56Z","timestamp":1571192156000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/8\/2137\/4995221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":17,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,5,11]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky180","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,5,11]]}}}